Eleuthero
Best-in-class: Eleuthero
A classic adaptogen for stamina, stress resilience and endurance — gentler and less stimulating than Panax ginseng.
Eleuthero quick facts
| Suggested dose | 300–1,200 mg extract daily. |
| How often | Daily |
| Who it's for | Stamina, endurance and everyday stress resilience. |
Milder than rhodiola and considerably milder than panax, which makes it a reasonable starting adaptogen for someone who finds the others overstimulating. Trial evidence covers stress tolerance and endurance and is decent rather than compelling. Long traditional use in Soviet occupational medicine, which is where most of the older literature comes from and is worth reading with that context.
How Eleuthero actually works
Eleutherosides acting as a classical adaptogen — modulating the HPA axis so the stress response is less exaggerated, rather than sedating or stimulating directly. It is not a ginseng despite being sold as Siberian ginseng, and the actives are structurally unrelated to ginsenosides.
Where to get Eleuthero
Find Eleuthero on iHerb →The evidence for Eleuthero
Graded by what exists behind each claim.
✅ Clinically validated
- Studies support improved endurance, reduced fatigue and stress resilience.
- Adaptogenic effects on the stress axis.
📊 Correlative data
- Studied extensively in Soviet-era occupational medicine, where it was given to factory workers, soldiers and athletes and tracked for productivity and illness rates. The scale of that exposure is genuinely large; the methodology by modern standards is not recoverable.
🧪 Theoretical / extrapolated benefits
- A milder daily adaptogen — good for sustained stamina without over-stimulation.
How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →
What Eleuthero actually does
Eleutherococcus senticosus is an Araliaceae shrub. It is in the same botanical family as Panax ginseng and shares no active chemistry with it: there are no ginsenosides in eleuthero. The marker compounds are the eleutherosides, a chemically unrelated collection — eleutheroside B is syringin, a phenylpropanoid glucoside; eleutheroside E is syringaresinol diglucoside, a lignan Patyra 2025. “Siberian ginseng” is a trade name and a reasoning trap: anybody who extrapolates from ginseng's pharmacology to this plant is extrapolating between molecules with nothing in common but a family tree.
The adaptogen mechanism, stated as precisely as it can honestly be stated. The proposed action is modulation of the hypothalamic-pituitary-adrenal axis and of the cellular stress-response machinery — heat shock protein expression, stress-activated protein kinases, cortisol dynamics — rather than agonism or antagonism at a single receptor Patyra 2025. That is a systems-level claim, and the honest consequence is worth printing: no eleuthero constituent has a named human receptor with a published binding affinity. Every other entry in this cohort can give you a Ki or an IC50. This one cannot, and that absence is information.
The one hard pharmacological fact has a clinical consequence. Eleuthero was implicated in raising a measured serum digoxin concentration in a patient taking both McRae 1996, and the published response argued the material involved was probably not Eleutherococcus at all but Periploca sepium Awang 1996. Both halves of that exchange are important, and they point in the same practical direction.
Cell, rodent, human — and where it stops
Cell: nothing to report, and that is the finding. The mechanism is HPA-axis and stress-protein modulation with no receptor affinity behind it Patyra 2025.
Human, the positive trial. Nine recreationally trained college males took 800 mg/day of Eleutherococcus senticosus or a starch placebo for 8 weeks in a double-blind randomized placebo-controlled crossover with a 4-week washout, cycling at 75% of VO2 peak to exhaustion. VO2 peak rose 12%, endurance time improved 23% and peak heart rate rose 4%, all p < 0.05, with higher plasma free fatty acids and lower glucose at 30 minutes of exercise Kuo 2010. Nine people.
Human, the null trials. Twenty highly trained distance runners took 3.4 mL of Eleutherococcus extract or placebo daily for 6 weeks inside an 8-week double-blind study, tested every two weeks with a 10-minute treadmill run at 10 km race pace and a maximal treadmill test. There were no differences in heart rate, oxygen consumption, minute ventilation, ventilatory equivalent, respiratory exchange ratio, perceived exertion, time to exhaustion or serum lactate Dowling 1996. And on the stress claim rather than the exercise one: adding eleuthero to stress-management training in people with stress-related fatigue, weakness or impaired work and concentration produced no benefit over the training alone Schaffler 2013.
The review that counts the score. Three studies suggesting that eleuthero substantially improves cardiorespiratory fitness, fat metabolism and endurance performance each contain severe methodological flaws that threaten their internal validity, while five studies using rigorous protocols show no benefit. The conclusion is that eleuthero at up to 1,000 to 1,200 mg/day for one to six weeks offers no advantage during exercise ranging from 6 to 120 minutes Goulet 2005.
The obstacle here is not the usual one, and that is what makes it interesting. There is no diagnosis gap: these trials enrolled healthy trained adults, which is exactly the reader. The gap is quality and it points the wrong way for the product. The positive result is nine people in a crossover Kuo 2010; the negative results are larger, better controlled and more numerous Dowling 1996 Goulet 2005 Schaffler 2013. And the Soviet-era occupational literature the card credits — factory workers, soldiers, athletes, illness and productivity records — is genuinely enormous in exposure and genuinely unrecoverable by modern standards, which means it cannot be weighed rather than that it weighs a lot.
Eleuthero — which form, and does it matter
The card's dose is a four-fold range with no extract ratio attached, and that range is doing no work. Three hundred to 1,200 mg of “extract” can mean a 1:1 or a 20:1 preparation, which differ twentyfold in plant equivalent. The one positive human trial used 800 mg/day for 8 weeks Kuo 2010; the review that found nothing covers up to 1,000–1,200 mg/day Goulet 2005; the null runner trial used a liquid extract measured in milliliters Dowling 1996. No two of those can be put on the same axis, which is precisely why the literature does not add up.
The number to demand is eleutheroside content. Pharmacopoeial eleuthero is specified on eleutheroside B and E Patyra 2025. A label reading “eleuthero root 500 mg” gives you a powder weight; “10:1 extract 250 mg” gives you a ratio and still no marker content; “standardized to 0.8% eleutherosides” gives you a dose you can compare between bottles.
Root, not stem, not leaf. The eleutheroside profile differs by plant part and stem bark is cheaper than root Patyra 2025. A product that does not say which part it used has told you it does not matter to them.
The identity problem is this plant's own and it is a century old. Periploca sepium, silk vine, has been sold as Siberian ginseng, and it is a different genus in a different family carrying cardiac-glycoside-like constituents. The digoxin case report McRae 1996 was met with the argument that the material was probably Periploca rather than Eleutherococcus Awang 1996. Whichever of the two is right, the buying rule is identical: on this shelf the species on the label has historically not always been the species in the bottle, so buy from a supplier that publishes a botanical identity test rather than only a heavy metals panel.
What would have to be true, and how you would know it was not
1. The performance read, done the way the positive trial did it. A fixed submaximal time-to-exhaustion test — same bike, same wattage, same time of day, caffeine held constant — at day 0 and day 56, on 800 mg/day. That is the dose and the duration that produced a 23% improvement in nine men Kuo 2010. Predict no change, because the larger and better-controlled trials found none Dowling 1996 Goulet 2005.
2. The prediction that cuts against the card's own text. The card calls this gentler and less stimulating than Panax and then warns that it causes insomnia and irritability if taken late. Both cannot be true. Test it: take 800 mg at 4 p.m. for two weeks with a 14-night sleep diary run first as a baseline, and score sleep-onset latency. Predict it lengthens. A compound stimulating enough to cost you sleep is not a gentle one, and finding out which sentence on the card is right is worth more than either claim.
3. Blood pressure, twice daily for two weeks before and two weeks on, because eleuthero has been reported to raise it in some people and a home cuff is cheap. Predict no change on average; treat any consistent rise as a reason to stop rather than to persist.
4. If you are diabetic, the glucose meter is the read-out. The positive trial found lower plasma glucose during exercise on eleuthero Kuo 2010. Predict little at rest and be alert during training if you take insulin or a sulfonylurea.
What will fool you: training itself. Eight weeks of consistent cycling raises VO2 peak in a recreationally trained person with no capsule at all, which is exactly why the positive trial used a crossover with a washout Kuo 2010 and why a before-and-after with no control arm cannot distinguish the herb from the habit.
What nobody has tested yet
Nobody has repeated the nine-person crossover at scale. The single positive endurance result Kuo 2010 has never been reproduced in a trial large enough to survive the methodological criticism that sank the earlier positive studies Goulet 2005. Forty trained cyclists, 800 mg, eight weeks, pre-registered, would settle it.
Nobody has related eleutheroside content to any outcome. Every trial reports milligrams of extract; none reports milligrams of eleutheroside B and E delivered Patyra 2025. There is therefore no exposure-response relationship for this plant in humans at all, which is why the null and positive trials cannot even be compared on dose.
Nobody has run the cortisol study the adaptogen claim implies. A salivary cortisol awakening response and a diurnal slope, before and after 8 weeks, in chronically stressed adults, against placebo. The one stress trial that exists tested eleuthero as an add-on to a psychological intervention and measured neither Schaffler 2013.
And nobody has surveyed the retail market for identity. The Periploca substitution argument is thirty years old Awang 1996 and no published DNA-barcoding survey of retail eleuthero has established how often it is still true. That is a weekend of sequencing and it would change what a consumer should do.
Eleuthero — its own safety story, not its category's
Digoxin is the interaction with a case behind it. Serum digoxin rose in a patient taking digoxin together with Siberian ginseng McRae 1996, and the published rebuttal argued the product was probably Periploca rather than Eleutherococcus Awang 1996. That exchange changes the mechanism and not the advice: whether the cause was a genuine transporter interaction or a cardiac-glycoside-containing adulterant, an unexplained digoxin level in someone taking a herbal supplement is a reason to ask what is in the bottle. If you take digoxin, clear this with the prescriber first.
It is stimulating, and the framing hides that. Insomnia and irritability with late dosing are the commonest complaints, and they are the opposite of what the word adaptogen implies to a buyer. Take it in the morning or not at all.
Blood pressure. Rises have been reported in some people, which is why uncontrolled hypertension is the one clear contraindication on this page even without a controlled trial behind it.
Glucose-lowering drugs. The one positive human trial found a metabolic shift with lower plasma glucose during exercise Kuo 2010. Anyone on insulin or a sulfonylurea should be watching a meter rather than assuming a herb is inert.
Pregnancy and breastfeeding: no data. That is not the same sentence as “safe.” These two groups are systematically excluded from every trial cited on this page, so the absence of harm reports is an absence of looking.
Who should not take it: anyone on digoxin without supervision McRae 1996 Awang 1996; anyone with uncontrolled hypertension; anyone on a glucose-lowering drug without monitoring; anyone taking it after midday who values their sleep; and anyone buying it instead of doing the eight weeks of consistent training that produced most of the effect in the only trial that found one Kuo 2010.
Sources read for this page
- Kuo J, Chen KW, et al. The effect of eight weeks of supplementation with Eleutherococcus senticosus on endurance capacity and metabolism in human. Chinese Journal of Physiology 2010 · PMID 21793317
- Goulet ED, Dionne IJ. Assessment of the effects of eleutherococcus senticosus on endurance performance. International Journal of Sport Nutrition and Exercise Metabolism 2005 · PMID 15902991
- Dowling EA, Redondo DR, et al. Effect of Eleutherococcus senticosus on submaximal and maximal exercise performance. Medicine and Science in Sports and Exercise 1996 · PMID 8778554
- Schaffler K, Wolf OT, Burkart M. No benefit adding eleutherococcus senticosus to stress management training in stress-related fatigue/weakness, impaired work or concentration, a randomized controlled study. Pharmacopsychiatry 2013 · PMID 23740477
- Patyra A, et al. Eleutherococcus root: a comprehensive review of its phytochemistry and pharmacological potential in the context of its adaptogenic effect. Frontiers in Pharmacology 2025 · PMID 41235111
- McRae S. Elevated serum digoxin levels in a patient taking digoxin and Siberian ginseng. Canadian Medical Association Journal 1996 · PMID 8705908
- Awang DV. Siberian ginseng toxicity may be case of mistaken identity. Canadian Medical Association Journal 1996 · PMID 8964001
How you would know if it worked
There is no blood test for this one. That is not a criticism — it is a fact about the effect, and it changes how you should judge it.
- What to watch: A repeatable physical effort with a number attached: the same route at the same pace, and how hard it felt out of ten. Its evidence is in endurance and fatigue resistance rather than mood, so the endpoint belongs in training rather than in how the day went.
- How long before it means anything: Six to eight weeks at 300 to 1,200 mg. It is the gentlest of the ginsengs, and gentle plus slow means an early read is not a read at all.
- What will fool you: Your own training. Six weeks of consistent work improves exactly the numbers you are scoring, which is the confound that makes every adaptogen look effective to anyone who started a program the same month. If the training changed, the trial is dead — run it inside a maintenance block, or keep the program identical.
Run it one variable at a time. Starting three things in one week means a result you cannot attribute, which is the same as no result.
Eleuthero — safety & side effects
- Insomnia and irritability if taken late; it is stimulating despite the 'adaptogen' framing.
- May raise blood pressure in some people. Interacts with digoxin (raises measured levels), and with diabetes medication.
- Avoid in uncontrolled hypertension. Not established as safe in pregnancy or breastfeeding — not because harm is documented, but because these are the two populations systematically excluded from the trials. Absence of data is not reassurance.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor — pharmacists are underused and free.
- When to take it, and what to take it with
- Which form actually absorbs
- Who it's worth it for
- Best-in-class brand pick
- Coach Cam's stacks and notes
- Fasted or with food, and when in the day
- Morning or night, and why that window
- Around training, or deliberately away from it
- What it must not share a window with
Everything above is free and stays free. Skool is where it becomes a plan — Eleuthero in an order, with the rest of what you're running.
Unlock in Skool — $10/mo →Bloodwork to run alongside Eleuthero
Baseline first, then again at 8–12 weeks.
| Marker | What it’s watching for |
|---|---|
| TSH (Thyroid-Stimulating Hormone) | Thyroid disease imitates every cognitive complaint there is |
| Vitamin B12 | Deficiency causes fog long before it causes anemia |
| Methylmalonic Acid (MMA) | Catches the deficiency a normal B12 hides |
| Ferritin | Low iron flattens cognition at levels most labs call fine |
| Vitamin D (25-Hydroxy) | Commonly low, cheap to correct, associated with mood |
The Brain Fog & Cognition panel covers these in one order — 12 markers, $233.06 with the discount applied.
Check results you already have → · All 103 markers A–Z
Eleuthero — frequently asked questions
What is Eleuthero?
A classic adaptogen for stamina, stress resilience and endurance — gentler and less stimulating than Panax ginseng.
What is the suggested dose of Eleuthero?
300–1,200 mg extract daily. This is a general reference for education only — statements have not been evaluated by the FDA and this is not medical advice.
Where can I find Eleuthero dosing and the full breakdown?
The suggested dose and the full evidence — clinical, correlative and theoretical — are on this page. What's inside Skool is when to take it, which form actually absorbs, the brand worth buying and Coach Cam's stacks.
Where can I buy Eleuthero?
Coach Cam sources Eleuthero from vetted, top-rated brands on iHerb — use the buy link on this page.
Eleuthero inside a finished plan
One arm of 1 Protocol Blueprint, free to read in full.
What Eleuthero is used for
Eleuthero appears under 2 goals in the goal router.
Related Cognitive & Mood supplements
Where this goes next
Eleuthero is the stress-driven arm of this plan. The page above is the free breakdown of one compound; the plan it belongs to — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.